Impact of risk minimisation measures on the use of strontium ranelate: a multi-national cohort study in 5 EU countries by the EU-ADR Alliance

Impact of risk minimisation measures on the use of strontium ranelate: a multi-national cohort study in 5 EU countries by the EU-ADR Alliance

Weitere Versionen anzeigen (1)

Bibliographische Detailangaben
Hauptverfasser:	Berencsi, K, Ali, M, Marinier, K, Deltour, N, Hawley, S, Pedersen, L, Rijnbeek, P, Duijnhoven, R, Van Der Lei, J, Lapi, F, Simonetti, M, Reyes-Reyes, C, Sturkenboom, M, Prieto-Alhambra, D
Format:	Conference item
Veröffentlicht:	Wiley 2017

Ähnliche Einträge

Impact of risk minimisation measures on the use of strontium ranelate: A multinational cohort study in 5 EU countries by the EU‐ADR Alliance
von: Berencsi, K, et al.
Veröffentlicht: (2018)

Comparative cardiovascular safety of strontium ranelate and bisphosphonates amongst patients with no contraindications: a multi-database study in our European countries by the EU-ADR Alliance
von: Ali, M, et al.
Veröffentlicht: (2017)

Comparative cardiovascular safety of strontium ranelate and bisphosphonates amongst patients with no contraindications: A multi‐database study in 5 EU countries by the EU‐ADR Alliance
von: Ali, M, et al.
Veröffentlicht: (2018)

A multi-database, multinational validation study of cardiovascular death, venous thromboembolic events and gastrointestinal diseases in the EU-ADR Alliance
von: Ying, H, et al.
Veröffentlicht: (2018)

The impact of risk minimisation measures on the incidence and prevalence of use of strontium ranelate at the population level: preliminary results of a multi-national cohort study including 5 European countries
von: Berencsi, K, et al.
Veröffentlicht: (2016)

STRONTIUM RANELATE: WHAT THE FUTURE HOLDS
von: Cooper, C
Veröffentlicht: (2011)

STRONTIUM RANELATE EFFECT ON KNEE OSTEOARTHRTTIS PROGRESSION
von: Zaim, S, et al.
Veröffentlicht: (2013)

PATHOGENESIS OF OSTEOARTHRITIS AND SUBSTANTIATION OF THE USE OF STRONTIUM RANELATE
von: Elena Mikhailovna Zaitseva, et al.
Veröffentlicht: (2014-02-01)

STRONTIUM RANELATE IS THE DRUG OF CHOICE IN THE TREATMENT OF OSTEOPOROSIS
von: Nataliya Vladimirovna Toroptsova
Veröffentlicht: (2010-09-01)

Strontium ranelate is a drug to treat osteoarthrosis
von: Oksana Anatolyevna Nikitinskaya
Veröffentlicht: (2013-03-01)

Bivalos (strontium ranelate) administration experience in postmenopausal osteoporosis
von: I A Skripnikova, et al.
Veröffentlicht: (2009-04-01)

STRUCTURE MODIFYING EFFECTS OF STRONTIUM RANELATE IN KNEE OSTEOARTHRITIS
von: Reginster, J, et al.
Veröffentlicht: (2012)

Strontium ranelate's dual action: A closer look
von: Russell, R
Veröffentlicht: (2006)

Strontium ranelate in the treatment of osteoporosis: evidence for its efficacy
von: N V Toroptsova, et al.
Veröffentlicht: (2010-02-01)

Pathogenetic treatment with strontium ranelate in women with postmenopausal osteoporosis
von: Olga Borisovna Yershova
Veröffentlicht: (2010-12-01)

STRONTIUM RANELATE AND RISK OF VENOUS THROMBOEMBOLISM (VTE): AN UPDATE OF A RETROSPECTIVE COHORT STUDY IN THE UK GENERAL PRACTICE RESEARCH DATABASE (GPRD)
von: Cooper, C, et al.
Veröffentlicht: (2012)

Strontium Ranelate Significantly Decreases Radiological Progression Using a New Definition For Radiological Progression In Patients With Primary Knee Osteoarthritis Treated With Strontium Ranelate
von: Bruyere, O, et al.
Veröffentlicht: (2013)

Effects of Strontium Ranelate On Knee Osteoarthritis Pain: A Responder Analysis
von: Reginster, J, et al.
Veröffentlicht: (2012)

EFFECT OF STRONTIUM RANELATE ON KNEE PAIN IN OSTEOARTHRITIS: A RESPONDER ANALYSIS
von: Cooper, C, et al.
Veröffentlicht: (2013)

Clinically Meaningful Effect of Strontium Ranelate On Knee Osteoarthritis Symptoms
von: Bruyere, O, et al.
Veröffentlicht: (2012)

Prevention Of Radiological Progression In Patients With Primary Knee Osteoarthritis With Strontium Ranelate
von: Reginster, J, et al.
Veröffentlicht: (2013)

Repurposing the Strontium Ranelate Antiosteoporotic Drug as a New Outstanding Biocompatible Blue Dye
von: Luca M. Sihn, et al.
Veröffentlicht: (2023-09-01)

STRONTIUM RANELATE EFFECT ON KNEE OSTEOARTHRITIS PROGRESSION: A MRI ANALYSIS
von: Genant, H, et al.
Veröffentlicht: (2013)

THE PLACE OF STRONTIUM RANELATE IN THE TREATMENT OF PATIENTS WITH OSTEOPOROSIS (RESULTS OF THE MARC PROGRAM)
von: O. A. Nikitinskaya, et al.
Veröffentlicht: (2018-09-01)

Strontium ranelate in the treatment of postmenopausal osteoporosis: results of administration in clinical practice
von: N V Toroptsova, et al.
Veröffentlicht: (2008-06-01)

Effect of Strontium Ranelate on Condylar Growth during Mandibular Advancement in Rats
von: Hasan Camcı, et al.
Veröffentlicht: (2020-12-01)

Strontium ranelate inhibits wear particle-induced aseptic loosening in mice
von: Tianxiang Geng, et al.
Veröffentlicht: (2018-07-01)

Long treatment with strontium ranelate of womenwith postmenopausal osteoporosis: 10-year results
von: J Y Reginster, et al.
Veröffentlicht: (2011-04-01)

Compositional and Material Properties of Rat Bone after Bisphosphonate and/or Strontium Ranelate Drug Treatment
von: Yuchin Wu, et al.
Veröffentlicht: (2013-01-01)

Strontium ranelate as a possible disease-modifying osteoarthritis drug: a systematic review
von: T.A. Rodrigues, et al.
Veröffentlicht: (2018-06-01)

Strontium Ranelate in Knee Osteoarthritis Trial (SEKOIA): A Structural and Symptomatic Efficacy.
von: Reginster, J, et al.
Veröffentlicht: (2012)

The Comparison of the Effect of Risedronate and Strontium Ranelate on Bone Mineral Density in Postmenopausal Women
von: Figen Yılmaz, et al.
Veröffentlicht: (2012-08-01)

Comparison of Effectiveness of Strontium Ranelate and Alendronate Sodium in Postmenopausal Osteoporosis - Original Investigation
von: Kurtuluş Kaya, et al.
Veröffentlicht: (2009-12-01)

Evaluation of Biocompatibility of New Osteoplastic Xenomaterials Containing Zoledronic Acid and Strontium Ranelate
von: Maksim V. Stogov, et al.
Veröffentlicht: (2023-06-01)

Effects of strontium ranelate on sutural bone formation: a histological and immunohistochemical study
von: Karataş Orhan H., et al.
Veröffentlicht: (2016-01-01)

STRONTIUM RANELATE PREVENTS SPINE OSTEOARTHRITIS PROGRESSION IN PATIENTS WITH PREVALENT SPINAL OSTEOARTHRITIS
von: O Bruyere, et al.
Veröffentlicht: (2007-08-01)

Effects of Strontium Ranelate on Spinal Interbody Fusion Surgery in an Osteoporotic Rat Model.
von: Tsung-Ting Tsai, et al.
Veröffentlicht: (2017-01-01)

The clinical effectiveness and cost-effectiveness of strontium ranelate for the prevention of osteoporotic fragility fractures in postmenopausal women
von: M Stevenson, et al.
Veröffentlicht: (2007-02-01)

Clinically meaningful effect of strontium ranelate on symptoms in knee osteoarthritis: a responder analysis.
von: Bruyère, O, et al.
Veröffentlicht: (2014)

STRONTIUM RANELATE REDUCES THE NUMBER OF RADIOLOGICAL OR RADIOCLINICAL PROGRESSORS IN PATIENTS WITH PRIMARY KNEE OSTEOARTHRITIS
von: Reginster, J, et al.
Veröffentlicht: (2012)